← SynDRA
TEMUTERKIB
SynDRA canonical compound SYN0040131 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MAPK1 | MAPK3 |
|---|
| Mechanism of action | ERK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MAPK3 INHIBITOR
- Mitogen-activated protein kinase; ERK1/ERK2 inhibitor
- MAPK1 INHIBITOR
Cross-references
Synonyms
- LY-3214996
- LY3214996
- JNPRPMBJODOFEC-UHFFFAOYSA-N
- GTPL9975
- SCHEMBL17837273
- MolPort-046-033-624
- EX-A2560
- BCP19982
- CS-6974
- HY-101494
- LY 3214996
- 6,6-dimethyl-2-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5-(2-morpholin-4-ylethyl)thieno[2,3-c]pyrrol-4-one
- 6,6-dimethyl-2-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-5-(2-morpholinoethyl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-4-one
- V0Q46LFE6F
- RefChem:187813
- ERK1/2 Inhibitor LY3214996
- Temuterkib [USAN]
- Temuterkib (USAN)
- C22H27N7O2S
- Temuterkib [WHO-DD]
- TEMUTERKIB [INN]
- UNII-V0Q46LFE6F
- orb1303171
- GLXC-10733
- [14c]-ly3214996
- BDBM50601918
- NSC803410
- s8534
- WHO 11680
- AKOS037515532
- CCG-269274
- NSC-803410
- NCGC00510704-02
- AC-35885
- BL166457
- BS-15775
- DA-65151
- LY3214996?
- T4091
Look up TEMUTERKIB in the interactive SynDRA portal →